Dear Colleague, New discoveries in stem cell research have made this an interesting and exciting time to be in this field. From the breakthrough discovery of reprogrammed human skin cells to act like embryonic stem cells to the development of "epiblast stem cells" from rat or mouse embryos making them also closely resemble human embryonic stem cells, the field of stem cell research is only at the beginning of its unlimited possibilities of cures.
With such great advancements in stem cell research, the need for a forum to share news and developments is a necessity to say the least. GTCbio's 4th International conference on Stem Cell Research and Therapeutics provides a comfortable environment for researchers and scientists to exchange ideas and brainstorm on novel pathways of discovery.
Taking place in Boston on April 17-18, near the Whitehead Institute at MIT and the Harvard Stem Cell Institute, the conference will feature leaders in the field, including Senator Richard Moore (D-Massachusetts) and Dr. Rudolf Jaenisch, Professor of Biology at MIT and founding member of the Whitehead Institute.
Abstract Submissions and Poster Presentations: To submit an abstract visit http://gtcbio.com/user_abstract.aspx. Submission deadline is March 17, 2008. Oral presenters from outstanding abstracts will be chosen! ADDITIONAL DISCOUNT You are eligible to receive a highly discounted rate to attend the conference. Receive a 30% discount when registering to attend. Or take advantage of our register 2, the 3rd person goes free rate! Please fill out the following form to register: www.gtcbio.com/SCPortal-RegForm.pdf.
Conference Highlights: - Differentiation of Stem Cells
+ Mapping the Embryome: Implications for the Manufacture of hES-Derived Cells
+ Regulation of Human Mesenchymal Stem Cells Differentiation by Novel Factors
+ Single ES Cell Profiling Reveals Unique MicroRNA Expression Signatures and Heterogeneities
- Regenerative Medicine & Therapeutics
+ Stimulation of Brain Neurogenesis: A Way to Replace Neuron Loss in Diseased or Injured Brain
+ Functional Regeneration of the Adult Central Nervous System
+ Pluripotent Stem Cells in the Treatment of Ischemic Disease
- Epigenomics & Reprogramming of Stem Cells
+ Quality Control of Cell Therapies Based on DNA Methylation Markers
- Stem Cell Imaging
+ Noninvasive Tracking of Cardiac Embryonic Stem Cells In Vivo Using Magnetic Resonance and Bioluminescence Imaging Techniques
+ Retention of Cells after Transplantation
- Cancer Stem Cells
+ Targeted Elimination of Cancer Stem Cells
+ Colon Cancer Stem Cells, Their Resistance and Differentiation
- Stem Cell Applications in Drug Discovery
+ Stem Cells as Screening Tools in Drug Discovery
+ Focus on Derivation of Hepatocytes
+ Embryonic Stem Cell-Derived Cellular Models
- Regulatory Aspects
+ Product Characterization Questions in Cell-based Therapies For a FULL AGENDA visit http://gtcbio.com/userAgenda.aspx?id=120.
Keynote Presentations: Senator Richard Moore, D-Massachusetts
"Stem Cells Legislation and Policy"
Rudolf Jaenisch, Ph.D., Founding Member, Whitehead Institute; Professor of Biology, MIT
"Stem Cells, Pluripotency and Nuclear Reprogramming"
Malcolm Moos, M.D., Ph.D., Medical Officer, Division of Cellular and Gene Therapies, FDA
"Product Characterization Questions in Cell-based Therapies"
Distinguished Speakers Basem Abdallah, Odense University Hospital Anne Bang, Novocell Miriam Bibel, Novartis Petter Björquist, Cellartis Caifu Chen, Applied Biosystems Yen Choo, Plasticell Limited Dennis O. Clegg, UCSB Eyleen Goh, Duke-NUS Graduate Medical School Singapore Austin Gurney, OncoMed Pharma Ulrich Hoffmueller, Epiontis Jeffrey Janus, International Stem Cell Corporation Christophe Labie, Sanofi Aventis Edward Lanphier, Sangamo BioSciences Jane S. Lebkowski, Geron Corp. Jan Paul Medema, Universiteit Van Amsterdam Huseyin Mehmet, Merck & Co. Malcolm Moos, FDA Jeffrey P. Norenberg, University of New Mexico Health Sciences Center
Jay Sharma, Celprogen Yanhong Shi, Beckman Research Institute, City of Hope David Taylor, University of Central Florida Mark Thiede, Pfizer, Inc. Anthony Ting, Athersys Bruce Wentworth, Genzyme Michael West, BioTime Nicholas Zavazava, University of Iowa For inquiries or more information, please contact Nina Tran at nina.tran@gtcbio.com or at 626-256-6405 x104.
Your Subscription:
Change your subscription
Unsubscribe | 
